JENBURPH exchange filings, corporate actions and results
4 Sep 2026
⚑ Filing
Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Change in DirectorateBSE filing · raw filing ↗
4 Sep 2026
⚑ Filing
Jenburkt Pharmaceuticals Ltd - 524731 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE filing · raw filing ↗
4 Sep 2026
⚑ Filing
Jenburkt Pharmaceuticals Ltd - 524731 - Proceedings Of The 41St Annual General Meeting Of The Company Held On Friday, 04Th September, 2026.BSE filing · raw filing ↗
4 Sep 2026
⚑ Filing
Jenburkt Pharmaceuticals Ltd - 524731 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE filing · raw filing ↗
4 Sep 2026
⚑ Filing
Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE filing · raw filing ↗
Ex-date 28 Aug 2026
⚑ Corp action
Dividend — ₹20.70 per shareNSE filing · record 28 Aug 2026
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
